Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
320
7 regions32 stories13 publishers12 countries
Top story
Israeli Ministry of Health extends medical cannabis licenses during conflict
Israel’s Ministry of Health has taken steps to ensure cannabis patients can continue to access the treatment following the outbreak of conflict in the region.
Cannabis HealthILMedical
- 01
Food Standards Agency drops recommended daily dose of CBD to 10mg
Cannabis HealthGBHemp & CBD
- 02
Business of Cannabis launches #BuyLocalNY campaign with CANY
Business of CannabisUSEvents & Industry
Europe
6 stories- Italian court temporarily blocks CBD reclassification
Business of CannabisITRegulation
- Oxford Cannabinoid Technologies publishes Phase I clinical trial results
Business of CannabisGBHealth & Science
- Data the new fertiliser for profitable cannabis cultivation and legalisation movement
Business of CannabisEvents & Industry
- Blossom Pharma receives GMP licences from Infarmed
CannaReporterPTMedical
- Hellenic Dynamics begins cultivation of medical cannabis flowers
morningstar.co.ukGBBusiness & Investment
- Cannabis Industry Council launches survey on UK banking challenges
Business of CannabisGBEvents & Industry
United States
6 stories- Two New York cannabis dispensaries set to open after court orders
Business of CannabisUSAdult-use
- New Jersey's Cannabis Equity Grant Programme receives US$12 million
Business of CannabisUSBusiness & Investment
- Connecticut records record-breaking cannabis sales exceeding US$25 million in September
Business of CannabisUSAdult-use
- Georgia becomes first state to allow pharmacies to dispense medical cannabis
Business of CannabisUSMedical
- Alaska approves regulations for intoxicating hemp products
Business of CannabisUSHemp & CBD
- Governor vetoes bill to bring Amsterdam-style cannabis cafes to California
Business of CannabisUSAdult-use
Canada
6 stories- Expert panel publish legislative review report of Canada's Cannabis Act
Business of CannabisCARegulation
- Curaleaf Holdings files TSX listing application for subordinate voting shares
Business of CannabisCABusiness & Investment
- Canadian cannabis farms eligible for federal funding under C$3.5 billion programme
MJBizDailyCABusiness & Investment
- Canopy Growth receives EU GMP Certification for Ontario facility
PR NewswireCAMedical
- Nova Scotia's Mernova Medicinal hits third consecutive quarter of revenue growth
theaustralian.com.auCABusiness & Investment
- Eurofins CDMO Alphora receives Health Canada Cannabis Drug License
Business WireCAMedical
LATAM & Caribbean
4 stories- Medical School in São Paulo launches Endocannabinology discipline
SechatBRMedical
- Cannabis makes first appearance at Argentina's National Flower Festival
El PlanteoAREvents & Industry
- FIFA-affiliated Costa Rican football team Herediano partners with CBD company
El PlanteoCRBusiness & Investment
- Barbados closer to launching domestic medicinal cannabis industry
El PlanteoBBRegulation
Africa & Middle East
2 stories- Medical cannabis patients in Israel increases by 1,100 in September
Cannabis Magazine (Israel)ILMedical
- IM Cannabis announces appointment of new Chief Financial Officer
PR NewswireILBusiness & Investment
APAC
1 story- Thailand's Prime Minister to reverse cannabis legalisation
CNBCTHRegulation
Oceania
3 stories- Althea Group Holdings management agree pay cut after positive cash flow quarter
CannabizAUBusiness & Investment
- Cannim Group completes acquisition of UK's Savage Cabbage Limited
Business of CannabisAUGBBusiness & Investment
- Sequel to Australian documentary on medical cannabis in the works
Hemp GazetteAUEvents & Industry
Stocks
- Weekly stock report
Business of CannabisBusiness & Investment
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report